Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | CEVP, Disc & Safety Assessment | October 05, 2026 | October 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date October 05, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,807 |
Ending reported balance
After 2026-10-05 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-10-05 · Exercise / conversion · Acquired 981 · Balance 5,788 Row 2 · 2026-10-05 · Sale · Disposed 981 · Balance 4,807 F1: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $208.44 · Expires 2034-05-31 | Direct | 2,944 |
Reported balance
After 2026-10-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-05 · Exercise / conversion · Disposed 981 · Balance 2,944 |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 9,680 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,680 |
| Common StockSEC Table I · non-derivative | Indirectby Karpathos Investments LLC | 28,510 |
Reported balance
Holding disclosure · report date 2026-10-05 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 28,510 |
Filing footnotes · ownership attribution and instrument terms
F1: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 05, 2026 Filed Oct 8, 2026 00:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 981 | $0.00 Strike: $208.44 | $0.00 |
DisclosureSEC source: 0001952784-26-000003 · wk-form4_1791419553.xml · derivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,944 Underlying: Common Stock · 981 shares Expires 2034-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2026 Filed Oct 8, 2026 00:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 981 | $308.44 | $302,579.64 |
DisclosureSEC source: 0001952784-26-000003 · wk-form4_1791419553.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,807 F1 · shares: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was adopted on March 4, 2026. Read SEC document |
| October 05, 2026 Filed Oct 8, 2026 00:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 981 | $208.44 | $204,479.64 |
DisclosureSEC source: 0001952784-26-000003 · wk-form4_1791419553.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 2,039 | $0.00 Strike: $194.12 | $0.00 |
DisclosureSEC source: 0001100682-26-000136 · form4.xml · derivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,039 Underlying: Common Stock · 2,039 shares Expires 2033-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,039 | $294.12 | $599,710.68 |
DisclosureSEC source: 0001100682-26-000136 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,807 F1 · shares: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:33 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 2,039 | $194.12 | $395,810.68 |
DisclosureSEC source: 0001100682-26-000136 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,714 | $0.00 Strike: $179.66 | $0.00 |
DisclosureSEC source: 0001100682-26-000130 · form4.xml · derivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,714 shares Expires 2030-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3,714 | $279.66 | $1,038,657.24 |
DisclosureSEC source: 0001100682-26-000130 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,807 F1 · shares: This exercise and sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. Read SEC document |
| August 11, 2026 Filed Aug 13, 2026 20:34 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,714 | $179.66 | $667,257.24 |
DisclosureSEC source: 0001100682-26-000130 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 05, 2026 Filed Aug 6, 2026 20:49 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 5,046 | $263.00 | $1,327,098.00 |
DisclosureSEC source: 0001100682-26-000120 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,807 F1 · shares: This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on March 4, 2026. Read SEC document |
| June 05, 2026 Filed Jun 8, 2026 20:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000105 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 9,680 F1 · shares: Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person. Read SEC document |
| June 05, 2026 Filed Jun 8, 2026 20:19 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 1,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000105 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,853 F1 · shares: Reflects the exempt transfer pursuant to Rule 16a-13 of 1,529 shares held by the reporting person to a revocable trust controlled by the reporting person. Read SEC document |
| May 31, 2026 Filed Jun 2, 2026 20:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 170 | $180.71 | $30,720.70 |
DisclosureSEC source: 0001100682-26-000087 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,382 Read SEC document |
| May 30, 2026 Filed Jun 2, 2026 20:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 551 | $180.71 | $99,571.21 |
DisclosureSEC source: 0001100682-26-000087 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,552 Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 4,361 | $180.71 | $788,076.31 |
DisclosureSEC source: 0001100682-26-000087 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,103 F1 · shares: Unvested restricted stock units annually ratably vest on: May 29, 2027; May 29, 2028; May 29, 2029; May 29, 2030. Read SEC document |
| May 27, 2026 Filed May 28, 2026 20:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 105 | $156.73 | $16,456.65 |
DisclosureSEC source: 0001100682-26-000083 · form4.xml · nonDerivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,742 Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 168 | $160.30 | $26,930.40 |
DisclosureSEC source: 0001100682-26-000083 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,847 Read SEC document |
| February 06, 2026 Filed May 28, 2026 20:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 7,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000083 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 8,151 F1 · shares: Reflects the exempt transfer pursuant to Rule 16a-13 of 7,169 shares held by the reporting person to a revocable trust controlled by the reporting person. Read SEC document |
| February 06, 2026 Filed May 28, 2026 20:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 7,169 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000083 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,015 F1 · shares: Reflects the exempt transfer pursuant to Rule 16a-13 of 7,169 shares held by the reporting person to a revocable trust controlled by the reporting person. Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 1,067 | $211.68 | $225,862.56 |
DisclosureSEC source: 0001100682-26-000004 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,184 Read SEC document |
| January 30, 2026 Filed Feb 2, 2026 21:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 4,236 | $0.00 | $0.00 |
DisclosureSEC source: 0001100682-26-000004 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,251 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 26, 2023. Read SEC document |
| May 31, 2025 Filed Jun 3, 2025 21:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 105 | $135.63 | $14,241.15 |
DisclosureSEC source: 0001127602-25-016559 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,997 Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 21:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 5,603 | $135.63 | $759,934.89 |
DisclosureSEC source: 0001127602-25-016559 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,102 F1 · shares: Unvested restricted stock units vest annually on: May 30, 2026; May 30, 2027; May 30, 2028; May 30, 2029. Read SEC document |
| May 28, 2025 Filed May 29, 2025 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 44 | $138.65 | $6,100.60 |
DisclosureSEC source: 0001127602-25-015903 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,499 Read SEC document |
| May 27, 2025 Filed May 29, 2025 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 65 | $136.73 | $8,887.45 |
DisclosureSEC source: 0001127602-25-015903 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,543 Read SEC document |
| May 26, 2025 Filed May 29, 2025 21:08 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 104 | $136.73 | $14,219.92 |
DisclosureSEC source: 0001127602-25-015903 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,608 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 471 | $165.57 | $77,983.47 |
DisclosureSEC source: 0001127602-25-002722 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,999 Read SEC document |
| January 31, 2025 Filed Feb 3, 2025 21:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-002722 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,470 F2 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 27, 2022. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 3,925 | $208.44 Strike: $208.44 | $818,127.00 |
DisclosureSEC source: 0001127602-24-017686 · form4.xml · derivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,925 Underlying: Common Stock · 3,925 shares Expires 2034-05-31 F2 · shares: Stock options vest as follows: 981 on May 31, 2025, 981 on May 31, 2026, 981 on May 31, 2027, and 982 on May 31, 2028. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:25 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 1,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-017686 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,406 F1 · shares: Unvested restricted stock units vest as follows: 431 on May 31, 2025, 432 on May 31, 2026, 432 on May 31, 2027, and 432 on May 31, 2028. Read SEC document |
| May 29, 2024 Filed May 31, 2024 00:18 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 110 | $214.51 | $23,596.10 |
DisclosureSEC source: 0001127602-24-017061 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,679 Read SEC document |
| May 28, 2024 Filed May 28, 2024 21:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 70 | $217.21 | $15,204.70 |
DisclosureSEC source: 0001127602-24-016728 · form4.xml · nonDerivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,764 Read SEC document |
| May 27, 2024 Filed May 28, 2024 21:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 105 | $217.21 | $22,807.05 |
DisclosureSEC source: 0001127602-24-016728 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,834 Read SEC document |
| May 26, 2024 Filed May 28, 2024 21:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 168 | $217.21 | $36,491.28 |
DisclosureSEC source: 0001127602-24-016728 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GiftCommon Stock | 412 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-008113 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Indirect · by Karpathos Investments LLC Disclosed balance after: 26,554 F2 · balance_after: Reflects the exempt transfer pursuant to Rule 16a-13 of 2,440 shares held by Karpathos Investments LLC to the reporting person. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $254.02 | $25,402.00 |
DisclosureSEC source: 0001127602-24-008113 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,132 Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 21:09 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 3,686 | $253.43 | $934,142.98 |
DisclosureSEC source: 0001127602-24-008113 · form4.xml · nonDerivative · entry 1 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,792 F1 · price: This transaction was executed in multiple trades at prices ranging from $252.99 to $253.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,882 | $0.00 Strike: $144.67 | $0.00 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · derivative · entry 11 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,882 shares Expires 2024-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 5,882 | $144.67 | $850,948.94 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 10 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,478 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 89 | $245.34 | $21,835.26 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 9 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,596 F9 · price: This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 749 | $244.61 | $183,212.89 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 8 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,685 F8 · price: This transaction was executed in multiple trades at prices ranging from $244.27 to $45.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 604 | $243.96 | $147,351.84 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 7 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,434 F7 · price: This transaction was executed in multiple trades at prices ranging from $243.26 to $244.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 632 | $242.43 | $153,215.76 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 6 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,038 F6 · price: This transaction was executed in multiple trades at prices ranging from $241.97 to $242.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 610 | $241.28 | $147,180.80 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 5 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,670 F5 · price: This transaction was executed in multiple trades at prices ranging from $240.83 to $241.71. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,617 | $240.12 | $388,274.04 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 4 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,280 F4 · price: This transaction was executed in multiple trades at prices ranging from $239.76 to $240.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,290 | $239.28 | $308,671.20 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,897 F3 · price: This transaction was executed in multiple trades at prices ranging from $238.73 to $239.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:32 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 291 | $237.20 | $69,025.20 |
DisclosureSEC source: 0001127602-24-005831 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,187 F2 · price: This transaction was executed in multiple trades at prices ranging from $236.71 to $237.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This sale occurred pursuant to a Rule 10b5-1 Trading Plan that was initially adopted on February 23, 2023. Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 555 | $220.28 | $122,255.40 |
DisclosureSEC source: 0001127602-24-002842 · form4.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,412 Read SEC document |
| January 29, 2024 Filed Feb 1, 2024 00:35 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-002842 · form4.xml · nonDerivative · entry 2 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,967 F1 · shares: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021. Read SEC document |
| January 29, 2024 Filed Mar 25, 2024 22:52 UTC Amendment | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 535 | $220.28 | $117,849.80 |
DisclosureSEC source: 0001127602-24-011126 · form4a.xml · nonDerivative · entry 3 Parisotto Shannon M · CIK 0001952784 · CEVP, Disc & Safety Assessment 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,387 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.